Similarly, in colorectal cancer (CRC), increased eEF2 phosphorylation, as demonstrated in Rpl24Bst mutant mice, significantly limits tumorigenesis, positioning translation elongation as a key therapeutic target [13]. This evidence concerns the gene EEF2 and colorectal cancer.